Skip to content

Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy

Randomized Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01320813
Enrollment
5
Registered
2011-03-23
Start date
2011-09-30
Completion date
2013-09-30
Last updated
2015-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Goiter, Graves Disease, Thyroiditis, Thyroid Nodule

Keywords

da vinci robot, Thyroidectomy

Brief summary

The main objective is to compare 12 month complication rates between a new surgical method for thyroidectomy (robot-assisted endoscopic thyroidectomy via a sub-clavical approach) and open thyroidectomy.

Interventions

PROCEDURERobot-assisted thyroidectomy

Patients will have a thyroidectomy via a robot-assisted (da Vinci robot) endoscopic (subclavical entry)surgical technique.

PROCEDUREOpen thyroidectomy

Patients will have a conventional (non-endoscopic) thyroidectomy using an open surgical technique

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is available for 12 months of follow-up * The patient is a candidate for total thyroidectomy because of a nodular pathology, a diffuse goiter, thyroiditis, or Basedow's disease * Patient has calcitoninemia \< 9 ng/pl * Patient has normal calcemia * Patient has PTH level between 5 ng/l and 75 ng/l * The subject has a normal laryngeal mobility

Exclusion criteria

* The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection, under tutorship or curatorship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * The patient is pregnant * The patient is breastfeeding * The patient is not available for 12 months of follow-up * Subject has a preoperative diagnosis of cancer on fine needle aspiration biopsy of the thyroid or cervical lymph node * Lymph node metastasis strongly suspected clinically and/or sonographically * The subject has an extension of substernal thyroid (diving goiter) * Family history of medullary thyroid cancer * The subject has a history of neck surgery * Contraindication for general anesthesia

Design outcomes

Primary

MeasureTime frameDescription
Presence/absence of complications (composite score)12 monthsThe per or post-operative occurrence of at least one of the following: postoperative hemorrhage requiring reintervention; cervical infection requiring antibiotics and/or surgical intervention; transient or persistent laryngeal paralysis; transient or persistent hypoparathyroidy (calcemia \< 1.9 µmol/l). Transiient means \< than and persistent means \>= 12 months.

Secondary

MeasureTime frameDescription
Patient satisfaction score12 monthsPatient satisfaction as regards the incision scar measured using a visual analog scale from 0.0 to 10.0.
Presence/absence of conversion to open technique1 dayFor patients in the robot arm: presence/absence of conversion to open technique.
Operating room prep time (min)1 dayTime in minutes necessary to prep the operating room
Presence/absence of per-operative complications1 dayPresence/absence of per-operative complications
Hospital stay (d)7 to 15 days post-opLength of hospitalization in days required after thyroidectomy
Change in thyroglobulinemia (ng/l)12 monthsThyroglobulinemia at 12 months - Thryoglobulinemia as baseline
Incision size (mm)12 monthsLength of incision in the open group, and sum of incision lengths in the robot group.
Change in phosphoremia (mg/l)Day 1Phosphoremia at 1 day postop - Phosphoremia at inclusion
Change in parathormonemia (ng/l)Day 1Parathormonemia on Day 1 post-op - parathormonemia at inclusion
Visual Analog Pain ScoreDay 1Visual Analog Scale for pain (0.0 to 10.0)
Direct medical costs (€)12 months
Indirect medical costs (€)12 months
Change in calcemia (mg/l)Day 1Calcemia on Day 1 - Calcemia at inclusion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026